MEDICALLY REVIEWED

Press Release: CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency

Last medically reviewed on 17 Aug 2023

CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based immunotherapies for the treatment of various cancers, announces today that it signed a Memorandum of Understanding (MOU) with Hangzhou CNK Therapeutics Co., Ltd (CNK).

Log In or Register as a healthcare professional to read the full article.

Gerald Ng

Gerald Ng is the current chief editor for Medical Channel Asia. Writing has always been his first love and he has more than a decade of journalism experience after falling in love with reading the newspapers daily growing up in Singapore. His works and interviews have appeared in various media publications including Yahoo!, Straits Times and Channel NewsAsia.

Share via

Also worth reading

Commentary: ENSŌ Beginner Series: The Squat

May 31, 2022

Introduction This series of articles will be catered towards the beginners, so we do not

nicotine poisoning e-cigarettes malaysia

The Rise of Nicotine Poisoning In Malaysia: A New Challenge

November 28, 2023

The Malaysian Council for Tobacco Control saw an increase in nicotine poisoning among teenagers due

Preventing Drug Interactions: Tips and Common Interactions

July 24, 2023

Unintended reactions between different medications commonly known as drug interactions can pose a considerable risk

People also read:

Chickenpox: Symptoms, Complications, and Treatment

Chickenpox is a highly contagious disease caused by the varicella-zoster virus (VZV). It presents as itchy rashes with fluid-filled blisters that spread from the trunk

May 26, 2022

Understanding Health Insurance: Coverage Options and Key Considerations for Singaporeans

Explore health insurance options in Singapore and considerations for choosing a plan to cover healthcare expenses. Read more

April 19, 2023

BREAKING: Singapore to relax COVID-19 measures in phases

Singapore has recently tightened measures to curb COVID-19, in view of the rising community and unlinked cases. This tightened measures were called the Phase 2

June 10, 2021

PUBLIC PORTAL

MEDICALLY REVIEWED

Press Release: CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency

Gerald Ng

Share via

Also worth reading

Commentary: ENSŌ Beginner Series: The Squat

The Rise of Nicotine Poisoning In Malaysia: A New Challenge

Preventing Drug Interactions: Tips and Common Interactions

People also read:

Chickenpox: Symptoms, Complications, and Treatment

Understanding Health Insurance: Coverage Options and Key Considerations for Singaporeans

BREAKING: Singapore to relax COVID-19 measures in phases

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

About Us

Advertise

Contact Us

My Account

Privacy Policy

FOLLOW MCA

ACCREDITATIONS

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

ACCREDITATIONS

Copyright © Medical Channel Asia 2022. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

Register to access the Medical Channel Asia HCP Portal. Get the latest healthcare news, expert insights, and exclusive interviews.

For Healthcare Professionals Only. Access is free.

Register to access the Medical Channel Asia HCP Portal. Get the latest healthcare news, expert insights, and exclusive interviews.

For Healthcare Professionals Only. Access is free.

PUBLIC PORTAL

MEDICALLY REVIEWED

Press Release: CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γδ T In Vivo Persistency

Gerald Ng

Share via

Also worth reading

People also read:

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

ACCREDITATIONS

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

ACCREDITATIONS

Copyright © Medical Channel Asia 2022. All rights reserved. The contents on Medical Channel Asia are for general educational purposes only. It is not intended to be a substitute for professional medical advice, treatment, or diagnosis. See additional information.

Register to access the Medical Channel Asia HCP Portal. Get the latest healthcare news, expert insights, and exclusive interviews. For Healthcare Professionals Only. Access is free.

Copyright © Medical Channel Asia 2022. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

Register to access the Medical Channel Asia HCP Portal. Get the latest healthcare news, expert insights, and exclusive interviews.

For Healthcare Professionals Only. Access is free.